share_log

Cellectar Biosciences 和 City of Hope 癌症中心进入合作评估类真菌病中的 Iopofosine I 131

Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Assess Iopofosine I 131 in Mycoid Diseases

Zhitong Finance ·  May 29 18:41
Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Assess Iopofosine I 131 in Mycoid Diseases

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment